100370-35-2

Usage

Uses

Used in Pharmaceutical Development:
N-(1,5-dihydroxypentan-2-yl)benzamide is used as a research compound for its potential biological activities, which may contribute to the development of new pharmaceuticals. Its unique structure and properties could be harnessed to target specific diseases or conditions, although more research is needed to determine its exact applications and efficacy.
Used in Chemical Research:
In the field of chemical research, N-(1,5-dihydroxypentan-2-yl)benzamide serves as a valuable compound for studying the properties and reactions of benzamide derivatives. Its structure allows researchers to explore various chemical modifications and interactions, potentially leading to the discovery of new compounds with novel therapeutic or industrial applications.
Used in Drug Discovery:
N-(1,5-dihydroxypentan-2-yl)benzamide is employed as a lead compound in drug discovery processes. Its unique chemical structure and potential biological activities make it a promising candidate for further optimization and development into effective therapeutic agents. Researchers can use N-(1,5-dihydroxypentan-2-yl)benzamide as a starting point to design and synthesize new drugs with improved pharmacological properties.
Used in Medicinal Chemistry:
In medicinal chemistry, N-(1,5-dihydroxypentan-2-yl)benzamide is utilized as a tool to understand the structure-activity relationships of benzamide-based compounds. By studying its interactions with biological targets and its pharmacological effects, researchers can gain insights into the design of more potent and selective drugs for various therapeutic areas.
Note: Since the provided materials do not specify particular applications or industries for N-(1,5-dihydroxypentan-2-yl)benzamide, the uses listed above are general and based on the potential of the compound as described. Further research and development would be required to identify specific applications in various industries.

Upstream product

• 86555-46-6 dimethyl (2S)-2-benzoylaminopentanedioate 
• 124126-80-3 N-benzoyl-L-glutamic acid α-methyl ester 
• 6094-36-6 N-benzoyl-L-glutamic acid 

Relevant academic research and scientific papers

Toward the development of chemoprevention agents. Part 1: Design, synthesis, and anti-inflammatory activities of a new class of 2,5-disubstituted-dioxacycloalkanes

A new class of 2,5-disubstituted-dioxacycloalkanes were designed and synthesized via stereoselective synthetic method as cancer chemoprevention agents. The anti-inflammatory activities of these compounds were tested using the xylene-induced mouse ear edema model. Some of these compounds exhibited comparable or better anti-inflammatory activities than that of aspirin suggesting that they can be further developed as potential anti-inflammatory drug lead compounds. In addition, treatment of these anti-inflammatory agents did not prolong tail bleeding time in mice. The structure/activity relationships were also analyzed among these compounds.

5-Benzoylamino-1,3-dioxacyclanes, the method for preparing the same and their use as PKC inhibitor

The present invention discloses a series of benzoylamino-1,3-dioxacyclane compounds, of which compounds 1-21 were prepared via transacetalisation reaction between N-benzoylaminoglycol and 1,1,3,3-tetramethoxypropane; while compounds 22-48 were prepared vi

Stereoselective transacetalization of 1,1,3,3-tetramethoxypropane and N- benzoylaminodiols

The transacetalization of 1,1,3,3-tetramethoxypropane and an N- benzoylaminodiol provided stereoselectively the corresponding 2,5- disubstituted-1,3-dioxanes. The stereochemistry of the rings formed in the transacetalization depended on the structure of the amino diol, and the ratio of the products depended on the reaction conditions, as expected. This kind of stereoselective transacetalization not only gives a series of useful building blocks but also generates interesting 1,3-dioxanes which target protein kinase C.